Infertility Markers in Serum, Urine, and Follicular Fluid
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00194220|
Recruitment Status : Completed
First Posted : September 19, 2005
Last Update Posted : September 30, 2015
This study is only collecting specimens from current patients of PENN Fertility Care.
The purpose of this investigation is to assess if markers of oxidative stress that are known to be associated with other medical conditions can be detected in women undergoing infertility treatment and normal women of similar age. Oxidative stress may affect a woman's eggs or the follicular cells that surround and nurture them. Other markers of to be investigated include markers of cellular aging and DNA structural changes.
Presence of these markers will be compared in blood and urine samples taken during infertility treatment, and follicular fluid at the time of IVF (if applicable).
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||1235 participants|
|Official Title:||Markers in Women Undergoing Infertility Treatment|
|Study Start Date :||September 2002|
|Actual Primary Completion Date :||July 2012|
|Actual Study Completion Date :||February 2013|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00194220
|United States, Pennsylvania|
|University of Pennsylvania Reproductive Research Unit|
|Philadelphia, Pennsylvania, United States, 19104|
|Principal Investigator:||Kurt T Barnhart, MD, MSCE||University of Pennsylvania|